Allogeneic Natural Killer and Cytomegalovirus (CMV)-pp65 Pulsed Dendritic Cells Induced Complete Response Through 15 Months in a Patient with Recurrent Glioblastoma: A Case Study

por Gumrukcu, Serhat, Nguyen, Tung X., White, Rachel L., Howell, Gregory T., Musikanth, Phillip
Publicado 2021

Age-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant natural killer T cells, γδ T cells, and mucosa-associated invariant T cells

por Singh, Parvind, Szaraz-Szeles, Marianna, Mezei, Zoltan, Barath, Sandor, Hevessy, Zsuzsanna
Publicado 2022

Case Report: Cerebrospinal Fluid Dynamics in the Optic Nerve Subarachnoid Space and the Brain Applying Diffusion Weighted MRI in Patients With Idiopathic Intracranial Hypertension—...

por Berberat, Jatta, Pircher, Achmed, Gruber, Philipp, Lovblad, Karl-Olof, Remonda, Luca, Killer, Hanspeter Esriel
Publicado 2022

Uterine Natural Killer Cell and Human Leukocyte Antigen-G1 and Human Leukocyte Antigen-G5 Expression in Vaginal Discharge of Threatened-Abortion Women: A Case-Control Study

por Shobeiri, Saeideh Sadat, Rahmani, Zahra, Hossein Nataj, Hadi, Ranjbaran, Hossein, Mohammadi, Masoud, Abediankenari, Saeid
Publicado 2015

Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study

por Mu, Ying, Wang, Wei-hua, Xie, Jia-ping, Zhang, Ying-xin, Yang, Ya-pei, Zhou, Chang-hui
Publicado 2016

Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study

por Xu, Yan, Wang, Jin, Zhang, Wanggang, Liu, Jie, Cao, Xingmei, He, Aili, Chen, Yinxia, Gu, Liufang, Lei, Bo, Zhang, Pengyu, Ma, Xiaorong
Publicado 2016

Erratum: Agrobacterium sp.-derived β-1,3-glucan enhances natural killer cell activity in healthy adults: a randomized, double-blind, placebo-controlled, parallel-group study

por Lee, Yeon Joo, Paik, Doo-Jin, Kwon, Dae Young, Yang, Hye Jeong, Park, Yongsoon
Publicado 2017

Retracted: Allogeneic Natural Killer and Cytomegalovirus (CMV)-pp65 Pulsed Dendritic Cells Induced Complete Response Through 15 Months in a Patient with Recurrent Glioblastoma: A Case Study

por Gumrukcu, Serhat, Nguyen, Tung X., White, Rachel L., Howell, Gregory T., Musikanth, Phillip
Publicado 2022

Adoptive immunotherapy with natural killer cells from peripheral blood CD34(+) stem cells to prevent hepatocellular carcinoma recurrence after curative hepatectomy: a study protocol for an open-label, single-arm phase I study

por Ohira, Masahiro, Kobayashi, Tsuyoshi, Tanaka, Yuka, Imaoka, Yuki, Sato, Koki, Imaoka, Koki, Nakano, Ryosuke, Doskali, Marlen, Piao, Jinlian, Nakamura, Mayuna, Yoshida, Tetsumi, Ichinohe, Tatsuo, Kawano, Reo, Yoshimura, Kenichi, Ueda, Keiko, Tamura, Natsuko, Hirata, Taizo, Imamura, Michio, Aikata, Hiroshi, Tanimine, Naoki, Kuroda, Shintaro, Tahara, Hiroyuki, Ide, Kentaro, Ohdan, Hideki
Publicado 2022

P1119: CAMRELIZUMAB PLUS LOW-DOSE APATINIB AND PEGASPARGASE FOLLOWED BY RADIOTHERAPY FOR NEWLY DIAGNOSED STAGE I/II NATURAL KILLER/T-CELL LYMPHOMA: A PROSPECTIVE MULTICENTER SINGLE-ARM STUDY

por Zhi-Ming, LI, Liu, Chuanxu, Sun, Peng, Tian, Shu, Ding, Hao, Tao, Rong
Publicado 2023

Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149

por Zhang, Lei, Jia, Sisi, Ma, Yangyang, Li, Ling, Li, Xin, Wang, Xinhua, Fu, Xiaorui, Ma, Wang, Qin, Yanru, Li, Wencai, Wu, Jingjing, Sun, Zhenchang, Zhang, Xudong, Nan, Feifei, Chang, Yu, Li, Zhaoming, Zhang, Dandan, Wang, Guannan, Yan, Jiaqin, Su, Liping, Wang, Jinghua, Xue, Hongwei, Young, Ken H., Zhang, Mingzhi
Publicado 2016

A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T‐cell lymphoma, nasal type: a multicenter trial in Northwest China

por Liang, Rong, Gao, Guang‐xun, Chen, Jie‐ping, Wang, Ji‐shi, Wang, Xiao‐min, Zeng, Yun, Bai, Qing‐xian, Zhang, Tao, Yang, Lan, Dong, Bao‐xia, Gu, Hong‐tao, Shu, Mi‐mi, Hao, Cai‐xia, Wang, Jian‐hong, Zhang, Na, Chen, Xie‐qun
Publicado 2016

A Phase I/II Dose-Escalation Multi-Center Study to Evaluate the Safety of Infusion of Natural Killer Cells or Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia: (RELEASE NCT04578210)

por Pérez-Martínez, Antonio, Martín-Quirós, Alejandro, Ferreras, Cristina, Al-Akioui, Karima, Mora-Rillo, Marta, Goterris, Rosa, Briones, María Luisa, Gasior, Mercedes, Amat, Paula, de Paz, Raquel, Guerra-García, Pilar, Queiruga-Parada, Javier, Bou, Merche, Mestre-Durán, Carmen, Borobia, Alberto, Carcas, Antonio J, Vicario, Jose Luis, Moreno, Miguel Ángel, Planelles, Dolores, Balas, Antonio, Eguizábal, Cristina, Soria, Bernat, Solano, Carlos
Publicado 2021

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study

por Zhao, Lingdi, Li, Tiepeng, Song, Yongping, Yang, Yonghao, Ma, Baozhen, Zhang, Yong, Shang, Yiman, Xu, Benling, Guo, Jindong, Qin, Peng, Han, Lu, Fu, Xiaomin, Lin, Hongwei, Liu, Liang, Ren, Xiubao, Wang, Zibing, Gao, Quanli
Publicado 2022

CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure

por Peek, Giles J, Clemens, Felicity, Elbourne, Diana, Firmin, Richard, Hardy, Pollyanna, Hibbert, Clare, Killer, Hilliary, Mugford, Miranda, Thalanany, Mariamma, Tiruvoipati, Ravin, Truesdale, Ann, Wilson, Andrew
Publicado 2006

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

por Muñoz Builes, Mario, Vela Cuenca, María, Fuster Soler, Jose L, Astigarraga, Itziar, Pascual Martínez, Antonia, Vagace Valero, Jose M, Tong, Hoi Y, Valentín Quiroga, Jaime, Fernández Casanova, Lucía, Escudero López, Adela, Sisinni, Luisa, Blanquer, Miguel, Mirones Aguilar, Isabel, González Martínez, Berta, Borobia, Alberto M, Pérez-Martínez, Antonio
Publicado 2020

Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination

por Wang, Yu, Wang, Cai-Qin, Sun, Peng, Liu, Pan-Pan, Yang, Hang, Wang, Han-Yu, Rao, Hui-Lan, Li, Su, Jiang, Wen-Qi, Huang, Jia-Jia, Li, Zhi-Ming
Publicado 2022

CD56(bright) natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

por Kariminia, Amina, Ivison, Sabine, Ng, Bernard, Rozmus, Jacob, Sung, Susanna, Varshney, Avani, Aljurf, Mahmoud, Lachance, Sylvie, Walker, Irwin, Toze, Cindy, Lipton, Jeff, Lee, Stephanie J., Szer, Jeff, Doocey, Richard, Lewis, Ian, Smith, Clayton, Chaudhri, Naeem, Levings, Megan K., Broady, Raewyn, Devins, Gerald, Szwajcer, David, Foley, Ronan, Mostafavi, Sara, Pavletic, Steven, Wall, Donna A., Couban, Stephan, Panzarella, Tony, Schultz, Kirk R.
Publicado 2017

A phase II prospective study of the “Sandwich” protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma

por Jiang, Ming, Zhang, Li, Xie, Li, Zhang, Hong, Jiang, Yu, Liu, Wei-Ping, Zhang, Wen-Yan, Tian, Rong, Deng, Yao-Tiao, Zhao, Sha, Zou, Li-Qun
Publicado 2017

Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial

por Specht, Hanno M., Ahrens, Norbert, Blankenstein, Christiane, Duell, Thomas, Fietkau, Rainer, Gaipl, Udo S., Günther, Christine, Gunther, Sophie, Habl, Gregor, Hautmann, Hubert, Hautmann, Matthias, Huber, Rudolf Maria, Molls, Michael, Offner, Robert, Rödel, Claus, Rödel, Franz, Schütz, Martin, Combs, Stephanie E., Multhoff, Gabriele
Publicado 2015